Log in to MyACC
Learn best practices and emerging science across practice-changing topics in care including cardiac arrhythmias, cardiovascular disease prevention, heart failure and cardiomyopathies, and vascular diseases.
Join leading experts in the field for this series of interactive sessions to ensure you are up to date on the safety and efficacy of the newest therapies, and cultivate your skills in applying the latest clinical information into patient care.
Learn to evaluate the benefits and risks between vitamin K antagonists (VKAs), direct oral anticoagulants (DOACs), and factor XI inhibitors, and their role in optimizing outcomes for patients with AFib, acute coronary syndromes, and comorbid ESRD and cancer.
Understand challenges of managing the cardiovascular and cardiometabolic care of patients with comorbidities such as obesity, diabetes and heart failure. Review current and emerging antiobesity medications and learn how to develop effective weight-management care plans that integrate lifestyle interventions and pharmacologic strategies.
Learn to integrate updated ablation techniques and guideline-based practices into personalized treatment plans for AFib. Discuss disparities in AFib care and implement strategies to ensure timely and equitable access to advanced interventions.
Learn to recognize the diverse clinical presentations of cardiac amyloidosis, differentiation from other conditions and employing multidisciplinary approaches for developing effective care pathways.
This series is supported by independent educational grants from Alnylam, AstraZeneca, Biosense Webster, Inc., Boston Scientific Corporation, BridgeBio Pharma, Inc., Bristol Myers Squibb and Janssen Pharmaceuticals, Inc., Alliance, Medtronic, and Novo Nordisk.
